Increased Binding of [ 18 F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus–Subiculum of Postmortem Human Parkinson's Disease Brain
Synapse · 2026
DOI: 10.1002/syn.70053 ↗At a glance
Journal article in Synapse, 2026. Written by Jogeshwar Mukherjee and 5 co-authors. Institution: Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, California, USA. Major MEDLINE topics: Receptors, Nicotinic, Parkinson Disease, Hippocampus. Cited 1 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIH HHS, NIA NIH HHS, NINDS NIH HHS.
Abstract (original language)
Non‐motor symptoms in Parkinson's disease (PD) may be influenced by the α4β2* subtype of nicotinic acetylcholine receptors (nAChRs) present in the hippocampus (HP) and subiculum (SUB). To continue efforts in positron emission tomography (PET) diagnostics for PD, autoradiographic [ 18 F]nifene binding to α4β2* nAChR was quantitatively assessed in the HP–SUB of PD ( n = 27; 14 males and 13 females) and cognitively normal (CN) ( n = 32; 16 males and 16 females) cases. Anti‐ubiquitin for Lewy body and anti‐α‐synuclein immunostaining on adjacent slices were analyzed in QuPath, and [ 18 F]nifene binding was quantified in OptiQuant. The SUB had greater [ 18 F]nifene binding (51%–85%) compared to HP in all cases. Significantly higher [ 18 F]nifene binding (>250%; p < 0.0001) was seen in PD SUB and PD HP compared to CN in both males and females. The grey matter (GM) to white matter (WM) ratio in PD = 3.53, whereas CN = 1.33, a >150% increase in PD ( p < 0.0001). Binding of [ 18 F]nifene to GM was >250% greater than WM in PD for both male and female. Male CN exhibited an increase, whereas male PD exhibited a significant decrease in [ 18 F]nifene binding with aging, whereas females did not exhibit significant differences. In summary, α4β2* nAChR measured by [ 18 F]nifene is significantly upregulated in the PD HP and SUB. This increased [ 18 F]nifene binding may be of diagnostic value using PET imaging.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Preclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, California, USA.
- Banner Sun Health Research Institute, Sun City, Arizona, USA.
Funding
- NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Cite
APA
Mukherjee, J., Karim, F., Ngo, A., Liang, C., Serrano, G. E., & Beach, T. G. (2026). Increased Binding of [ 18 F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus–Subiculum of Postmortem Human Parkinson's Disease Brain. Synapse. https://doi.org/10.1002/syn.70053
Vancouver
Mukherjee J, Karim F, Ngo A, Liang C, Serrano GE, Beach TG. Increased Binding of [ 18 F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus–Subiculum of Postmortem Human Parkinson's Disease Brain. Synapse. 2026. doi:10.1002/syn.70053
BibTeX
@article{Mukherjee2026,
author = {Mukherjee, Jogeshwar and Karim, Fariha and Ngo, Allyson and Liang, Christopher and Serrano, Geidy E and Beach, Thomas G},
title = {Increased Binding of [ 18 F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus–Subiculum of Postmortem Human Parkinson's Disease Brain},
journal = {Synapse},
year = {2026},
doi = {10.1002/syn.70053}
}
EUVIMED